Me. Masterson et al., PRECLINICAL EVALUATION OF THE RELIABILITY OF A 50 MEV RACETRACK MICROTRON, International journal of radiation oncology, biology, physics, 28(5), 1994, pp. 1219-1227
Citations number
9
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: A 50 MeV racetrack microtron has been installed and tested at
Memorial Sloan-Kettering Cancer Center. It is designed to execute mul
ti-segment conformal therapy automatically under computer control usin
g scanned X ray and electron beams from 10 to 50 MeV. Prior to accepta
nce of the machine from the manufacturer, formal reliability testing w
as carried out. Only in this way could confidence be gained in its use
fulness for routine 3D computer-controlled conformal therapy. Material
s and Methods: To assess reliability, a set of 25 multi-segment test c
ases, each consisting of 10 to 17 fixed segments, was developed. The f
ield arrangements and modalities for some of the test cases were ident
ical to 3D conformal treatments that were being delivered with multipl
e static fields on conventional linear accelerators at our institution
. Other cases were designed to explore reliability under more complex
sets of conditions. These cases were ''treated'' repeatedly during a t
otal period of 45 hours, over 5 days. During the treatments, ion chamb
ers attached to the head of the machine provided dosimetric data for e
ach field. Data from sensors connected to every set-up parameter (for
example, couch positions, gantry angle, collimator leaf positions, etc
.) were recorded and verified by an external computer. Results: While
preliminary tests indicated an interlock rate of 5%, final reliability
test results demonstrated an interlock fault rate of approximately 0.
5%. The reproducibility of dosimetric data and geometric setup paramet
ers was within specifications. As an example, leaf position reproducib
ility in the patient plane was within 0.5 mm for 97% of the setups. Th
e times required to carry out treatments were recorded and compared wi
th the times to carry out identical treatments on a conventional linea
r accelerator with cerrobend blocks. Areas where additional time savin
gs can be achieved were identified. Conclusion: As an integral part of
acceptance testing, the Scanditronix MM50 was rigorously tested for r
eliability. The machine successfully passed these tests, providing inc
reased confidence in its usefulness for routine 3D conformal therapy.